Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 14/20 | 1.00 |
| ▸ | PIM1 | P11309 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29382880 | 0.88 | ERN1 (1.00) | ERN1TDP1ALDH1A1CYP3A4TSHR | |
| SCHEMBL294059 | 0.88 | ERN1 (1.00) | ERN1TDP1ALDH1A1CYP3A4TSHR | |
| SCHEMBL30689082 | 0.88 | ERN1 (0.78) | ERN1PIM1 | |
| SCHEMBL456670 | 0.88 | ERN1 (0.78) | ERN1PIM1 | |
| SCHEMBL27998889 | 0.86 | ERN1 (0.96) | ERN1TDP1ALDH1A1CYP3A4TSHR | |
| SCHEMBL29956081 | 0.86 | ERN1 (0.75) | ERN1 | |
| SCHEMBL28337241 | 0.86 | ERN1 (0.96) | ERN1TDP1ALDH1A1CYP3A4TSHR | |
| SCHEMBL3664243 | 0.86 | ERN1 (0.75) | ERN1 | |
| SCHEMBL30294924 | 0.86 | ERN1 (0.96) | ERN1TDP1ALDH1A1CYP3A4TSHR | |
| SCHEMBL3207260 | 0.84 | ERN1 (0.72) | ERN1PIM1TDP1ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118388787-A | Preparation of Salamo type copper (II) semiconductor polymer and method for converting macromolecule into micromolecule | 兰州交通大学 | 2024-07-26 | — | — | CN | claimed |
| CN-113801100-B | Tetranuclear copper complex and preparation method and application thereof | 四川省产品质量监督检验检测院 | 2022-05-06 | — | — | CN | claimed |
| CN-113845535-B | Binuclear cadmium complex and preparation method and application thereof | 四川省产品质量监督检验检测院 | 2022-03-08 | — | — | CN | claimed |
| CN-113845535-A | Binuclear cadmium complex and preparation method and application thereof | 四川省产品质量监督检验检测院 | 2021-12-28 | — | — | CN | claimed |
| CN-113801100-A | Tetranuclear copper complex and preparation method and application thereof | 四川省产品质量监督检验检测院 | 2021-12-17 | — | — | CN | claimed |
| CN-101417961-A | Anion receptor based on nitro phenylhydrazone and phenolic hydroxyl and preparation of anion test paper and use thereof | UNIV NORTHWEST NORMAL (CN) | 2009-04-29 | — | — | CN | claimed |
| EP-1386603-A1 | Use of diamines having at least one quaternised group and dialdehydes for dyeing keratin fibres | L'OREAL (FR) | 2004-02-04 | — | — | EP | claimed |
| CN-119954759-A | Benzopyran COX-2 inhibitor and application thereof | 安炎达医药技术(广州)有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-118388787-A | Preparation of Salamo type copper (II) semiconductor polymer and method for converting macromolecule into micromolecule | 兰州交通大学 | 2024-07-26 | — | — | CN | disclosed |
| CN-114621408-B | Solid polymer electrolyte | 北京大学 | 2023-03-31 | — | — | CN | disclosed |
| CN-114621408-A | Solid polymer electrolyte | 北京大学 | 2022-06-14 | — | — | CN | disclosed |
| CN-113801100-B | Tetranuclear copper complex and preparation method and application thereof | 四川省产品质量监督检验检测院 | 2022-05-06 | — | — | CN | disclosed |
| CN-113845535-B | Binuclear cadmium complex and preparation method and application thereof | 四川省产品质量监督检验检测院 | 2022-03-08 | — | — | CN | disclosed |
| EP-0656362-B1 | Macrocyclic compounds and their use as pharmaceuticals | LILLY CO ELI (GB) | 1999-09-01 | — | — | EP | disclosed |
| WO-1998047890-A1 | SUBSTITUTED BENZOPYRAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1998-10-29 | — | — | WO | disclosed |
| US-5580900-A | TREATMENT OF DISEASES OF CENTRAL NERVOUS SYSTEM | LILLY INDUSTRIES LIMITED (GB) | 1996-12-03 | — | — | US | disclosed |
| US-5574158-A | CRYPT COMPOUNDS, NERVOUS SYSTEM DISORDERS, CHELATE COMPOUNDS | LILLY INDUSTRIES LIMITED (GB) | 1996-11-12 | — | — | US | disclosed |
| US-5428065-A | Treating central nervous system disorders | LILLY INDUSTRIES LIMITED (GB) | 1995-06-27 | — | — | US | disclosed |
| EP-0656362-A1 | Novel compounds | LILLY INDUSTRIES LIMITED (GB) | 1995-06-07 | — | — | EP | disclosed |
| EP-0645370-A1 | Substituted m-xylylene diamines for the treatment of diseases of the central nervous system | LILLY INDUSTRIES LIMITED (GB) | 1995-03-29 | — | — | EP | disclosed |